Hypertensive Crises (Q22306070)

PubMed

PubMed publication ID

8 February 2023

1

Paul E. Marik

Paul E

Marik

1 reference

PubMed

PubMed publication ID

17565029

Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor?

8 February 2023

language of work or name

English

0 references

publication date

June 2007

0 references

published in

Chest

0 references

volume

131

0 references

issue

6

0 references

page(s)

1949-1962

0 references

cites work

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Management of hypertension in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Blood Pressure After Stroke

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Prophylaxis strategies for contrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Duration of hydralazine action in hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Pharmacology and pharmacokinetics of esmolol.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Neurotoxic effects of sodium nitroprusside in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Comparison of nitroglycerin with nifedipine in patients with hypertensive crisis or severe hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Sodium nitroprusside and intracranial pressure.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Current concepts in treatment of hypertensive emergencies

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Coronary and systemic hemodynamic effects of nicardipine.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Clinical pharmacology, pharmacodynamics and interactions with esmolol

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Use of esmolol in hypertension after cardiac surgery.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Influence of labetalol on cocaine-induced coronary vasoconstriction in humans

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Involvement of nitric oxide in nitroprusside-induced hepatocyte cytotoxicity

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Effect of L-type calcium channel modulators on stimulant-induced hyperactivity.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Effects of nicardipine on left ventricular function and energetics in man.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Pathophysiological events leading to the end-organ effects of acute hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Nifedipine in hypertensive emergencies: a prospective study

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Congestive heart failure and pulmonary edema for the emergency physician

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Nicardipine versus placebo for the treatment of postoperative hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

1 reference

7 January 2021

Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Cytotoxic effect of sodium nitroprusside on PC12 cells.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Letter: Intravenous labetalol in severe hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Negligible sublingual absorption of nifedipine

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Labetalol treatment of cocaine toxicity.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

The use of labetalol in the management of cocaine crisis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Acute thoracic aortic dissection: the basics.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Laragh's lessons in pathophysiology and clinical pearls for treating hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Intravenous nicardipine in the treatment of postoperative arterial hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Hydralazine kinetics in hypertensive patients after intravenous administration

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Hydralazine kinetics after single and repeated oral doses

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Enalaprilat, an intravenous angiotensin-converting enzyme inhibitor, in hypertensive crises

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Use of phentolamine for cocaine-induced myocardial ischemia

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

The management of cocaine-associated myocardial ischemia

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Surgery of the thoracic aorta

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

The pathogenesis of acute pulmonary edema associated with hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Aortic dissection: new aspects of diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Risk factors for hypertensive crisis: importance of out-patient blood pressure control

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Clevidipine in adult cardiac surgical patients: a dose-finding study

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertension.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Nicardipine infusion for postoperative hypertension after surgery of the head and neck

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Esmolol for severe hypertension following repair of aortic coarctation

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Nitroprusside-Induced Formation of Cyanide and Its Detoxication with Thiosulfate During Deliberate Hypotension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipine.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Prevalence of blood pressure cuff sizes in a referral practice of 430 consecutive adult hypertensives

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Diagnosis, prevention, and management of eclampsia

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Severe preeclampsia and eclampsia: systolic hypertension is also important

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Labetalol infusion in acute myocardial infarction with systemic hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Acute treatment of hypertensive crisis with nifedipine

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Autoregulation of brain circulation in severe arterial hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Treating hypertension after stroke

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Acute dissection of the thoracic aorta. Esmolol is safer than and as effective as labetalol

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Spontaneous resolution of a dissection of the descending aorta after medical treatment with a beta blocker and a calcium antagonist

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

European Stroke Initiative Recommendations for Stroke Management – Update 2003

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Hypertensive urgencies and emergencies. Prevalence and clinical presentation

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Blood pressure course in patients with acute stroke and matched controls

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Effect of intravenous nimodipine on blood pressure and outcome after acute stroke

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Outcomes of medical management of acute type B aortic dissection.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Comparison of the effects of nicardipine and sodium nitroprusside for control of increased blood pressure after coronary artery bypass graft surgery.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

A pilot study of drug-induced hypertension for treatment of acute stroke

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Outcome of medically treated Stanford type B aortic dissection

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Nitroprusside-related cyanide poisoning. Time (long past due) for urgent, effective interventions

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

The diagnosis and management of hypertensive crises

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Clinical, diagnostic, and management perspectives of aortic dissection

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Effect of intra-arterial sodium nitroprusside on intracranial pressure and cerebral autoregulation

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

"Hypertensive emergency": a useful diagnostic category

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Hypertensive emergency: case criteria, sociodemographic profile, and previous care of 100 cases

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Current management of hypertensive emergencies

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Guidelines for the drug treatment of hypertensive crises

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Labetalol and other agents that block both alpha- and beta-adrenergic receptors.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021

Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.06-2490

7 January 2021